Mercer Global Advisors
HRMY icon

Mercer Global Advisors’s Harmony Biosciences HRMY Stock Holding History

Mercer Global Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$988K Buy
27,145
+12,366
+84% +$390K ﹤0.01% 1754
2026
Q1 		$414K Buy
14,779
+754
+5% +$24.7K ﹤0.01% 2131
2025
Q4 		$525K Buy
+14,025
New +$461K ﹤0.01% 1822
2023
Q1 		– Sell
-4,011
Closed -$221K – 1992
2022
Q4 		$221K Buy
+4,011
New +$221K ﹤0.01% 1656

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mercer Global Advisors's HRMY Position: Q2 2026 in Review

Mercer Global Advisors increased its Harmony Biosciences (HRMY) stake by 84% in Q2 2026, buying an estimated $390K and bringing the position to 27,145 shares worth $988K. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

Mercer Global Advisors first reported a position in HRMY in Q4 2022 and has held it in 4 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Mercer Global Advisors held 27,145 shares of Harmony Biosciences worth $988K as of Q2 2026.
  • Mercer Global Advisors bought 12,366 Harmony Biosciences shares in Q2 2026, an estimated $390K.
  • Harmony Biosciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1754 holding.
  • Mercer Global Advisors first reported a position in Harmony Biosciences in Q4 2022 and has held it in 4 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.